Sign in
Taking people in United StatesNo phase

Computer alerts to prompt cholesterol medicine for people with peripheral artery disease

Tests a computer alert for doctors and patients with peripheral artery disease.

Key facts

Who runs it
Brigham and Women's Hospital
Where
Boston, United StatesSee the site
Trial code
Registry title
Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy
Status
Recruiting
People taking part
400 people, planned
Started
1 Mar 2023
Expected to end
30 Dec 2026
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Computer Alert
Record updated
17 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with peripheral artery disease (PAD, narrowed leg arteries) who are not taking any medicine to lower LDL cholesterol. It tests an on-screen alert to their doctors.

Age
18 years and older
Sex
All sexes
Disease stage
Peripheral artery disease (PAD) recorded in the medical history, visit diagnosis or problem list. Patients seen in Cardiovascular Medicine, Primary Care, Podiatry, Vascular Surgery or Diabetology clinics.
Earlier treatment
Must not currently be prescribed LDL-C-lowering therapy.

Main reasons for not taking part

  • Taking a statin
  • Taking ezetimibe or bempedoic acid
  • Taking a PCSK9 inhibitor or inclisiran
  • Taking a combination of these medicines

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • All patients ≥ 18 years old
  • Seen in Cardiovascular Medicine Clinic, Primary Care, Podiatry, Vascular Surgery, and Diabetology
  • Medical history entry, visit diagnosis, or problem list entry of PAD
  • Not prescribed LDL-C-lowering therapy

Who cannot take part

  • Patients taking a statin, ezetimibe, bempedoic acid, a PCSK9 inhibitor, inclisiran or a combination will be excluded

Where in United States

  • Brigham and Women's HospitalBoston, United StatesContact: Gregory Piazza, MD, MSTaking people

About the trial

What the trial wants to find out

This single-center, 400-patient, randomized controlled trial assesses the impact of a patient- and provider-facing EPIC Best Practice Advisory (BPA; alert-based computerized decision support tool) to increase guideline-directed utilization of statin and statin-alternative oral LDL-C lowering therapies in patients with PAD who are not being prescribed LDL-C-lowering therapy.

The 2 groups in the trial

  • AlertTreatment being tested

    Alert-based CDS will consist of an on-screen electronic alert that will notify the clinician that the patient has an indication for LDL-C-lowering therapy but is not prescribed any. The clinician will have the opportunity to proceed to an order template through which appropriate lipid-lowering can be prescribed. The clinician could also elect to learn more about current evidence-based recommendations for LDL-C lowering in the PAD population. Finally, the clinician could elect to proceed without ordering oral LDL-C-lowering therapy or reading evidence-based recommendations for LDL-C lowering but would have to provide a rationale for not doing so.

    Treatment: Computer Alert

  • No AlertNo study treatment, for comparison

    No on-screen notification will be issued to the clinician

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy
Plain-language title
Computer alerts to prompt cholesterol medicine for people with peripheral artery diseaseGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
17 June 2026